11 Depression Clinical Trials in San Francisco, CA (2026)

Q: How do I join a clinical trial in San Francisco?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you.

Recruiting Depression Studies in San Francisco

NCT06966401Recruiting

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

This study will evaluate the long-term safety and tolerability of NBI-1065845 as an adjunctive treatment in participants with MDD....

San Francisco, CAPHASE3850 participantsNeurocrine Biosciences

View Study Details

NCT07573150Recruiting

Pupillometry in Identifying Risk of Postoperative Opioid-induced Respiratory Depression in Children Undergoing Tonsillectomy

This study will evaluate whether quantitative pupillometry measurements can be used to identify children at risk for postoperative opioid-induced respiratory depression (OIRD) following tonsillectomy....

San Francisco, CA300 participantsNeurOptics Inc

View Study Details

NCT07186816Recruiting

SUpport From PEeRs to Expand Access Study - Community

Investigators will evaluate the implementation of an evidence-based, Spanish-language, digital, cognitive-behavioral therapy (dCBT) intervention (SilverCloud) in the Mission community for Latino patie...

San Francisco, CANA213 participantsUniversity of California, Berkeley

View Study Details

NCT06911112Recruiting

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

The study will evaluate the efficacy of NBI-1065845 compared with placebo as an adjunctive treatment in participants with MDD on improving symptoms of depression....

San Francisco, CAPHASE3200 participantsNeurocrine Biosciences

View Study Details

NCT06091527Recruiting

Treating Major Depression With Yoga Mono-therapy

The goal of this single-center, single-blind, randomized, controlled, parallel group, interventional trial is to evaluate antidepressant efficacy of yoga monotherapy of 12-weeks duration in 180 adults...

San Francisco, CANA180 participantsUniversity of California, San Francisco

View Study Details

NCT07592689Recruiting

A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

A Phase 3 Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating DT120 Compared to Placebo in Major Depressive Disorder - Ascend...

San Francisco, CAPHASE3165 participantsDefinium Therapeutics US, Inc.

View Study Details

NCT07115329Recruiting

A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

The goal of this clinical trial is to learn if zelquistinel works to treat depression in adults. It will also learn about the safety of zelquistinel. The main questions it aims to answer are: Does ze...

San Francisco, CAPHASE2164 participantsSyndeio Biosciences, Inc

View Study Details

NCT02434393Recruiting

Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression Project

The purpose of this research study is to characterize the mechanisms contributing to cognitive impairment and accelerated cognitive decline in Late Life Depression (LLD). This is a non-randomized, ob...

San Francisco, CA120 participantsUniversity of Southern California

View Study Details

NCT04061148Recruiting

Near Infrared Spectroscopy (NIRS) for Assessment of Depression

Develop a NIRSIT testing protocol that can be administered in the diagnostic setting and reliably distinguishes the symptoms and severity of depression, with the help of repeated measure (up to five v...

San Francisco, CANA90 participantsUniversity of California, San Francisco

View Study Details

NCT06898788Recruiting

Probiotic Administration for Adolescent Depression

This double-blind, placebo-controlled clinical trial will examine the effect of probiotic Visbiome on the brain and gut microbiome of individuals 15 to 24 years of age....

San Francisco, CAEARLY_PHASE177 participantsUniversity of California, San Francisco

View Study Details

NCT04004169Recruiting

Closed-Loop Deep Brain Stimulation for Major Depression

Neurons are specialized types of cells that are responsible for carrying out the functions of the brain. Neurons communicate with electrical signals. In diseases such as major depression this electric...

San Francisco, CANA12 participantsAndrew Krystal

View Study Details

About Depression Clinical Trials in San Francisco

Depression (major depressive disorder) is a common and serious mood disorder that negatively affects how you feel, think, and handle daily activities. It affects over 280 million people globally. Treatment includes psychotherapy, antidepressant medications, and brain stimulation therapies.

There are currently 11 depression clinical trials recruiting participants in San Francisco, CA. These studies are seeking a combined 2,371 participants. Research is being sponsored by Neurocrine Biosciences, NeurOptics Inc, University of California, Berkeley and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Depression Clinical Trials in San Francisco — FAQ

Are there depression clinical trials in San Francisco?

Yes, there are 11 depression clinical trials currently recruiting in San Francisco, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Francisco?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you about next steps.

Are clinical trials in San Francisco free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Francisco studies also compensate for your time and travel.

What depression treatments are being tested?

The 11 active trials in San Francisco are testing new therapies including novel drugs, biologics, and treatment approaches for depression.

Data updated September 1, 2026 from ClinicalTrials.gov